Literature DB >> 11085597

Mutation analysis of the hCHK2 gene in primary human malignant gliomas.

Y Ino, D C Wahrer, D W Bell, D A Haber, D N Louis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11085597     DOI： 10.1007/pl00022979

Source DB:  PubMed          Journal:  Neurogenetics        ISSN： 1364-6745            Impact factor:   2.660


× No keyword cloud information.
  7 in total

1.  CHEK2 mutations in primary glioblastomas.

Authors:  Satu-Leena Sallinen; Tarja Ikonen; Hannu Haapasalo; Johanna Schleutker
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

2.  Loss of 22q chromosome is related to glioma progression and loss of 10q.

Authors:  Florence Laigle-Donadey; Emmanuelle Crinière; Alexandra Benouaich; Emmanuelle Lesueur; Karima Mokhtari; Khe Hoang-Xuan; Marc Sanson
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

3.  Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.

Authors:  Massimo Squatrito; Cameron W Brennan; Karim Helmy; Jason T Huse; John H Petrini; Eric C Holland
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

Review 4.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 5.  CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.

Authors:  Victoria Hale; Maren Weischer; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-11-06

6.  Aberrant signaling pathways in glioma.

Authors:  Mitsutoshi Nakada; Daisuke Kita; Takuya Watanabe; Yutaka Hayashi; Lei Teng; Ilya V Pyko; Jun-Ichiro Hamada
Journal:  Cancers (Basel)       Date:  2011-08-10       Impact factor: 6.639

7.  Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Authors:  Ulrika Andersson; Carl Wibom; Kristina Cederquist; Steina Aradottir; Ake Borg; Georgina N Armstrong; Sanjay Shete; Ching C Lau; Matthew N Bainbridge; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Richard S Houlston; Joellen Schildkraut; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel H Lachance; Margaret Wrensch; Faith G Davis; Ryan Merrell; Christoffer Johansen; Siegal Sadetzki; Melissa L Bondy; Beatrice S Melin
Journal:  Neuro Oncol       Date:  2014-04-09       Impact factor: 12.300
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.